GLP-1 agonists can help treat different components of polyendocrine metabolic ovarian syndrome (PMOS), as well as related ...

A new review argues that the mitochondrial peptide MOTS-c acts as a context-dependent stress signal with protective roles in ...

Researchers have engineered salamander-inspired gold-silver nanocages that cascade-target injured kidney cells and their ...

Older adults with metabolic fatty liver disease who started a class of diabetes and weight-loss medicines had fewer liver ...

Older adults with inflammatory arthritis often face delayed diagnosis, but primary care providers can be the first step to ...

What Research Shows About Cancer Risk and Prevention / Breast Cancer, cancer, Cancer Prevention, Cancer research, cancer risk ...

GLP-1 RAs outperformed mineralocorticoid receptor antagonists (MRAs) in cardiovascular protection in resistant hypertension and obesity.

Type 1 diabetes requires lifelong insulin therapy, while some people with Type 2 diabetes can achieve drug-free remission ...

Valeriia Simanovskaia, founder and CEO of Biobrokers, argues the next competitive frontier in the GLP-1 market is not another obesity drug but ...

Post-Discharge Antiseizure Medication Use and Poststroke Survival: An Emulated Target Trial in Older Adults [RCT emulation ...

Rest and nutrition are the foundation for recovering from severe muscle soreness after training or injuries to muscles, ...

Anti-obesity pills and a triple agonist, retatrutide, are the highly anticipated innovations expected in the near future for ...